BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2330 related articles for article (PubMed ID: 16334758)

  • 1. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
    Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
    Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of lymph node metastasis in T1 colorectal carcinoma.
    Yamamoto S; Watanabe M; Hasegawa H; Baba H; Yoshinare K; Shiraishi J; Kitajima M
    Hepatogastroenterology; 2004; 51(58):998-1000. PubMed ID: 15239233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.
    Lim SB; Yu CS; Jang SJ; Kim TW; Kim JH; Kim JC
    Dis Colon Rectum; 2010 Apr; 53(4):377-84. PubMed ID: 20305435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.
    Wang HS; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Chang SC; Lin JK
    Dis Colon Rectum; 2005 Jun; 48(6):1182-92. PubMed ID: 15793641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.
    Berberoglu U
    Hepatogastroenterology; 2004; 51(60):1689-93. PubMed ID: 15532806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
    Wang WS; Chen PM; Chiou TJ; Liu JH; Fan FS; Lin TC; Jiang JK; Yang SH; Yen CC; Wang HS; Lin JK
    Hepatogastroenterology; 2000; 47(36):1590-4. PubMed ID: 11149009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
    Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer.
    Suzuki A; Togashi K; Nokubi M; Koinuma K; Miyakura Y; Horie H; Lefor AT; Yasuda Y
    Am J Surg Pathol; 2009 Nov; 33(11):1601-7. PubMed ID: 19574884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
    Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
    J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of pathological risk factors for lymph node metastasis in colorectal cancer.
    Fang W; Fan B; Xiong B
    Hepatogastroenterology; 2009; 56(91-92):663-6. PubMed ID: 19621676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rule of lymph node metastasis in colorectal cancer and its affecting factors].
    Tu SL; Ye ZY; Deng GL; Zhao ZS; Dong QJ; Zheng BA; Ding LP; Cao HF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):257-60. PubMed ID: 17520386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
    Yasuda K; Inomata M; Shiromizu A; Shiraishi N; Higashi H; Kitano S
    Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
    Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
    Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
    Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
    Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the preoperative levels of CEA in patients with colorectal cancer.
    Marchena J; Acosta MA; Garcia-Anguiano F; Simpson H; Cruz F
    Hepatogastroenterology; 2003; 50(52):1017-20. PubMed ID: 12845969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 117.